BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16846927)

  • 1. Influence of allergy on the symptoms and treatment of nasal polyposis.
    Bonfils P; Avan P; Malinvaud D
    Acta Otolaryngol; 2006 Aug; 126(8):839-44. PubMed ID: 16846927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of allergy in patients with nasal polyposis after endoscopic sinus surgery.
    Bonfils P; Malinvaud D
    Acta Otolaryngol; 2008 Feb; 128(2):186-92. PubMed ID: 17851917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological study in patients with nasal polyposis].
    Toledano Muñoz A; Herráiz Puchol C; Navas Molinero C; García Simal M; Navarro Cunchillos M; Galindo Campillo AN
    Acta Otorrinolaringol Esp; 2008 Nov; 59(9):438-43. PubMed ID: 19080774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Widal syndrome always a severe disease?].
    Tudorache V; Mihăicuţă S; Potre R; Melcescu E
    Pneumologia; 2006; 55(3):105-8. PubMed ID: 17144478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis.
    Ehnhage A; Olsson P; Kölbeck KG; Skedinger M; Dahlén B; Alenius M; Stjärne P;
    Allergy; 2009 May; 64(5):762-9. PubMed ID: 19191775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nasal polyps is not a homogenous pathology].
    Arcimowicz M; Balcerzak J; Samoliński BK
    Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal suppression and osteoporosis after treatment of nasal polyposis.
    Bonfils P; Halimi P; Malinvaud D
    Acta Otolaryngol; 2006 Dec; 126(11):1195-200. PubMed ID: 17050313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the surgical treatment of nasal polyposis. II: Influence of a non-specific bronchial hyperresponsiveness.
    Bonfils P; Avan P
    Acta Otolaryngol; 2007 Aug; 127(8):847-54. PubMed ID: 17762997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis.
    Batra PS; Tong L; Citardi MJ
    Laryngoscope; 2013 Dec; 123 Suppl 7():S1-11. PubMed ID: 24122826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of pulmonary function in patients with nasal polyposis.
    Lamblin C; Brichet A; Perez T; Darras J; Tonnel AB; Wallaert B
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):406-13. PubMed ID: 10673178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization).
    Jankowski R; Bodino C
    Rhinology; 2003 Dec; 41(4):220-30. PubMed ID: 14750349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of nasal polyposis in France: a cross-sectional, case-control study.
    Klossek JM; Neukirch F; Pribil C; Jankowski R; Serrano E; Chanal I; El Hasnaoui A
    Allergy; 2005 Feb; 60(2):233-7. PubMed ID: 15647046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis.
    Bonfils P; Avan P
    Acta Otolaryngol; 2004 Apr; 124(3):290-6. PubMed ID: 15143747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis.
    Small CB; Stryszak P; Danzig M; Damiano A
    J Allergy Clin Immunol; 2008 Apr; 121(4):928-32. PubMed ID: 18234321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of allergy in the severity of nasal polyposis.
    Erbek SS; Erbek S; Topal O; Cakmak O
    Am J Rhinol; 2007; 21(6):686-90. PubMed ID: 17883886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases].
    Braun JJ; Haas F; Conraux C
    Ann Otolaryngol Chir Cervicofac; 1992; 109(4):189-99. PubMed ID: 1485748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence rates in endonasal surgery for polyposis.
    Albu S; Tomescu E; Mexca Z; Nistor S; Necula S; Cozlean A
    Acta Otorhinolaryngol Belg; 2004; 58(1):79-86. PubMed ID: 15517841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.